Bill Title: Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Spectrum: Bipartisan Bill

Status: (Introduced) 2025-01-10 - print number 265a [A00265 Detail]

Text: Latest bill text (Amended) [HTML]

---

Sponsors

Name	Type	Sponsorship	District	Financial	Encyclopedia	Biography
Assemblymember Phillip Steck [D]	Primary	Sponsored Bills	HD-110	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Michael Novakhov [R]	Cosponsor	Sponsored Bills	HD-045	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Joseph DeStefano [R]	Cosponsor	Sponsored Bills	HD-003	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Jo Simon [D]	Cosponsor	Sponsored Bills	HD-052	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Maritza Davila [D]	Cosponsor	Sponsored Bills	HD-053	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Scott Bendett [R]	Cosponsor	Sponsored Bills	HD-107	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Lester Chang [R]	Cosponsor	Sponsored Bills	HD-049	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Dana Levenberg [D]	Cosponsor	Sponsored Bills	HD-095	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember David Weprin [D]	Cosponsor	Sponsored Bills	HD-024	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Amy Paulin [D]	Cosponsor	Sponsored Bills	HD-088	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Keith Brown [R]	Cosponsor	Sponsored Bills	HD-012	FollowTheMoney	Ballotpedia	VoteSmart
Assemblymember Carrie Woerner [D]	Primary	Sponsored Bills	HD-113	FollowTheMoney	Ballotpedia	VoteSmart

Social Comments on NY A00265